BostonGene logo

Annals of Oncology • 2024-09-14

Molecular profiling from next-generation sequencing (NGS) reveals new potential therapeutic targets in patients with pediatric-type sarcomas

1 min to read

Authors

Anthony Conley², Aida Aukhadieva¹, Irina Zhuk¹, Marina Voropaeva¹, Anna Novokreshchenova¹, Aleksei Shevkoplias¹, Konstantin Zirov¹, Anastasia Makarova¹, Angelina Dubrovskaya¹, Anna Nadiryan¹, Linda Balabanian¹, Alexander Bagaev¹, Edwin Choy³, Ravin Ratan², Lev Bedniagin¹, Sant Chawla⁴
  1. BostonGene Inc., Waltham, USA
  2. The University of Texas MD Anderson Cancer Center, Houston, USA
  3. Massachusetts General Hospital, Boston, USA
  4. Sarcoma Oncology Research Center, Santa Monica, USA
Read full publication